Are you familiar with the new Sunshine Act regulations? One of our partners, Jesse Witten, explains here why private equity firms with medical device and pharma portfolio companies need to be aware of the new Sunshine Act regulations. Companies must begin to collect data on August 1, 2013, and the first annual report will be due on March 31, 2014 and will be available on the CMS public website.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.